Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boom We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
“Having a really good product, partnering with others in the ecosystem, and supporting education for patients, will allow us to be part of making a big dent in this obesity and type 2 diabetes health concerns for India,” Winselow Tucker, president and general manager of Eli Lilly and Company (India), told ET. In an exclusive…
Eli Lilly Donanemab secures CDSCO nod for early symptomatic Alzheimer’s Disease We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Amid the weight-loss drug frenzy, the India heads of Eli Lilly and Novo Nordisk — makers of the world’s most coveted obesity drugs — lay out their playbooks ahead of the March expiry of semaglutide’s patent. In exclusive interviews with Rica Bhattacharyya, Eli Lilly’s Winselow Tucker and Novo Nordisk’s Vikrant Shrotriya detail their strategies on…
Danish drugmaker Novo Nordisk on Tuesday cut the price of its blockbuster weight-loss drug, Wegovy, by up to 33% in India, according to a document seen by Reuters. Wegovy’s highest dose of 2.4 mg will now cost 16,400 rupees ($186.59), compared with its earlier price of 24,389.06 rupees, the document sent by Novo to drug…
President Trump last week hailed his deal with pharma companies to cut the price of blockbuster weight loss drugs as a major win for his administration and for increasing drug affordability. The question is how big of a difference the agreement will make for patients. The deal is expected to significantly expand access to GLP-1…
Novo Nordisk has partnered with India‘s Emcure Pharmaceuticals to exclusively distribute and market its weight-loss drug under a new brand in the country, the companies said on Monday. Under the agreement, the Danish drugmaker will sell Poviztra 2.4 milligram (mg) semaglutide injection in India as a separate brand of its blockbuster weight-loss treatment Wegovy. Shares…
From Launch to Leadership: Mounjaro Crosses Rs 333 Crore, Becomes India’s Top-Selling Drug We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Eli Lilly‘s weight-loss therapy Mounjaro became India’s top-selling drug by value in October, data showed on Friday, overtaking GSK’s widely used antibiotic Augmentin, as demand surges in the world’s most populous nation. The U.S. drugmaker’s popular injectable therapy raked in 1 billion rupees ($11.38 million) in October, research firm Pharmarack said. That outpaced Augmentin sales…
WASHINGTON — Health Secretary Robert F. Kennedy Jr. was uncharacteristically chummy with pharma executives at the White House on Thursday as he cheered the Trump administration’s plan for lowering obesity medication prices. Kennedy has railed against drugmakers in the past, and his lifestyle-focused “Make America Healthy Again” movement has opposed Medicare coverage of GLP-1 weight loss…